A/S Novo Insider Trading $RETA REATA PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for A/S Novo.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of A/S Novo. A/S Novo is 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Apollo Endosurgery, Inc. ($LPTN) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in KalVista Pharmaceuticals, Inc. ($KALV) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in REATA PHARMACEUTICALS INC ($RETA) and 10% Owner in ANAPTYSBIO INC ($ANAB) and 10% Owner in iRhythm Technologies, Inc. ($IRTC) and 10% Owner in Milestone Pharmaceuticals Inc. ($MIST) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Checkmate Pharmaceuticals, Inc. ($CMPI) and 10% Owner in Morphic Holding, Inc. ($MORF) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Reneo Pharmaceuticals, Inc. ($RPHM) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in SPRUCE BIOSCIENCES, INC. ($SPRB) and 10% Owner in Harmony Biosciences Holdings, Inc. ($HRMY).

A/S Novo in REATA PHARMACEUTICALS INC

Trading Symbol: RETA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of A/S Novo: 10% Owner
Holdings: 642,405 shares
Current Value: $14,794,587
Latest Transaction: Jun 23 2017
$RETA Market Capitalization: $515.29M
$RETA Previous Close: $23.03

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of A/S Novo in REATA PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALGS, ANAB, LPTN, BMTI, BOLT, CMPI, CLCD, CRVS, EAR, EWTX, ETTX, FLXN, GRTX, HRMY, HTGM, INGN, INZY, IRTC, OPHT, KALV, MIST, MIRM, MORF, NKTX, PRAX, RARX, RETA, RPHM, SPRB, TBRA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 23 2017RETAREATA PHARMACEUTIC ...Novo Holdings A/S10% OwnerOption ExerciseS0.001,200,00001,201,969
Jun 14 2017RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerSellS25.0349,6111,241,853592,794642.4 K to 592.8 K (-7.72 %)
Jun 14 2017RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerSellS25.4711,389290,073642,405653.8 K to 642.4 K (-1.74 %)
Jun 12 2017RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerSellS25.2890,3032,282,824653,794744.1 K to 653.8 K (-12.14 %)
Jun 12 2017RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerSellS25.892,20056,955744,097746.3 K to 744.1 K (-0.29 %)
Jun 12 2017RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerSellS26.00130,0003,380,000746,297876.3 K to 746.3 K (-14.84 %)
Jun 07 2017RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerSellS28.042,00056,079876,297878.3 K to 876.3 K (-0.23 %)
Jun 07 2017RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerSellS28.0964,1701,802,490878,297942.5 K to 878.3 K (-6.81 %)
Jun 07 2017RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerSellS28.6723,327668,825942,467965.8 K to 942.5 K (-2.42 %)
Jun 02 2016RETAREATA PHARMACEUTIC ...Novo A/S10% OwnerBuyP11.00750,0008,250,000750,0000 to 750 K

Page:   1